Ghazala Haque

Global Safety Medical Director

Role
Global Safety Medical Director- Hematology-oncology at Amgen
Location
Chapel Hill, NC, US
LinkedIn followers
500 followers
Healthcare & Human ServicesView LinkedIn profile

About Ghazala Haque

Dr. Ghazala Haque has vast expertise in all aspects of Adverse Event (AE) reporting from clinical studies for drugs, biologics, and devices. She is a subject matter expert in the specifications and implementation of Argus Safety databases. Her academic focus is clinical trial methodology and endpoint classification. Dr. Haque is constantly searching for better, more efficient ways of collecting and evaluating endpoints and AEs while maintaining impeccable data quality. She received her M.D. degree from Sind Medical College in Karachi, Pakistan, and a Master of Health Sciences in Clinical Research from Duke.

Experience

  1. Global Safety Medical Director- Hematology-oncology

    Amgen

    Jan 2025 — Present

Education

  • Durham Technical Community College

    Clinical Trials Research Associate Certification Program

    1999

  • Duke University

    Master of Health Sciences in Clinical Research

    2003

  • Sindh Medical College

    M.B.B.S. (MD), Bachelor of Medicine and Bachelor of Surgery

    1991

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Ghazala Haque — Global Safety Medical Director- Hematology-oncology at Amgen in Chapel Hill, NC, US | Unifers